Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Exosomes contribute to endothelial integrity and acute chest syndrome risk: Preliminary findings.

Lapping-Carr G, Khalyfa A, Rangel S, Darlington W, Beyer EC, Peddinti R, Cunningham JM, Gozal D.

Pediatr Pulmonol. 2017 Nov;52(11):1478-1485. doi: 10.1002/ppul.23698. Epub 2017 May 9.

PMID:
28486752
2.

Causes and Diagnosis of Abnormal Vaginal Bleeding.

Sokol E, Peddinti R.

Pediatr Ann. 2015 Jul;44(7):e164-7. doi: 10.3928/00904481-20150710-09.

PMID:
26171705
3.

Outpatient Management of Febrile Children With Sickle Cell Disease.

Sokol E, Obringer E, Palama B, Hageman J, Peddinti R.

Clin Pediatr (Phila). 2016 Mar;55(3):268-71. doi: 10.1177/0009922815594345. Epub 2015 Jul 6.

PMID:
26149843
4.

Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.

Ostler KR, Yang Q, Looney TJ, Zhang L, Vasanthakumar A, Tian Y, Kocherginsky M, Raimondi SL, DeMaio JG, Salwen HR, Gu S, Chlenski A, Naranjo A, Gill A, Peddinti R, Lahn BT, Cohn SL, Godley LA.

Cancer Res. 2012 Sep 15;72(18):4714-23. doi: 10.1158/0008-5472.CAN-12-0886. Epub 2012 Jul 18.

5.

Long term induction by pterostilbene results in autophagy and cellular differentiation in MCF-7 cells via ROS dependent pathway.

Chakraborty A, Bodipati N, Demonacos MK, Peddinti R, Ghosh K, Roy P.

Mol Cell Endocrinol. 2012 May 15;355(1):25-40. doi: 10.1016/j.mce.2012.01.009. Epub 2012 Jan 16.

PMID:
22273805
6.

Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth.

Kakodkar NC, Peddinti RR, Tian Y, Guerrero LJ, Chlenski A, Yang Q, Salwen HR, Maitland ML, Cohn SL.

Pediatr Blood Cancer. 2012 Oct;59(4):642-7. doi: 10.1002/pbc.24004. Epub 2011 Dec 6.

PMID:
22147414
7.

A 20-year-old male with back pain. Neuroblastoma.

Batra S, Gupta A, Peddinti R.

Pediatr Ann. 2010 Oct;39(10):610-3. doi: 10.3928/00904481-20100922-03. No abstract available.

PMID:
20954606
8.

The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth.

Kakodkar NC, Peddinti R, Kletzel M, Tian Y, Guerrero LJ, Undevia SD, Geary D, Chlenski A, Yang Q, Salwen HR, Cohn SL.

Pediatr Blood Cancer. 2011 Jan;56(1):164-7. doi: 10.1002/pbc.22639.

9.

Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.

Chlenski A, Guerrero LJ, Peddinti R, Spitz JA, Leonhardt PT, Yang Q, Tian Y, Salwen HR, Cohn SL.

Mol Cancer. 2010 Jun 4;9:138. doi: 10.1186/1476-4598-9-138.

10.

Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors.

Zeine R, Salwen HR, Peddinti R, Tian Y, Guerrero L, Yang Q, Chlenski A, Cohn SL.

Mod Pathol. 2009 Jul;22(7):950-8. doi: 10.1038/modpathol.2009.52. Epub 2009 May 1.

11.

Prominent microvascular proliferation in clinically aggressive neuroblastoma.

Peddinti R, Zeine R, Luca D, Seshadri R, Chlenski A, Cole K, Pawel B, Salwen HR, Maris JM, Cohn SL.

Clin Cancer Res. 2007 Jun 15;13(12):3499-506.

12.

SPARC enhances tumor stroma formation and prevents fibroblast activation.

Chlenski A, Guerrero LJ, Yang Q, Tian Y, Peddinti R, Salwen HR, Cohn SL.

Oncogene. 2007 Jul 5;26(31):4513-22. Epub 2007 Jan 29.

PMID:
17260013

Supplemental Content

Loading ...
Support Center